Narcolepsy and Pregnancy: What to Discuss With Your Doctor Before and During Pregnancy

People with narcolepsy can become pregnant and have healthy pregnancies, but pregnancy requires advance planning around medication, daytime sleepiness, cataplexy, safety, and care after birth. Evidence specific to narcolepsy in pregnancy remains limited, so decisions about treatment need to consider both potential medication risks and the consequences of poorly controlled symptoms.\[1,2\]

The most useful time to start that conversation is before trying to conceive, when possible.

What should you discuss before trying to get pregnant?

A preconception appointment should review every narcolepsy medication, symptom severity, contraception, daily safety needs, and how symptoms might be managed if treatment changes.

Ideally, this discussion involves the clinician managing the narcolepsy and the healthcare professional providing pregnancy care.

European narcolepsy guidance recommends reviewing treatment before a planned pregnancy and, where feasible, discontinuing narcolepsy medication beforehand because pregnancy-safety evidence is limited. The same guideline acknowledges that stopping treatment can substantially worsen symptom control and recommends individualized decisions when complete discontinuation is not practical.\[1\]

That balance matters. For someone with relatively manageable daytime sleepiness, reducing medication may have different consequences than it would for someone who experiences uncontrollable sleep attacks, frequent cataplexy, or safety problems without treatment.

A medication review should therefore not only ask "Is this medicine safe during pregnancy?" It should also ask "What happens to my daily safety and functioning if we change it?"

Which narcolepsy medications need particular attention during pregnancy?

Every narcolepsy medicine should be reviewed individually because pregnancy recommendations and available evidence differ between drugs.

For modafinil, European regulators have continued to advise against routine use during pregnancy because of concerns about potential fetal risk. In 2025, the EMA's Pharmacovigilance Risk Assessment Committee reviewed additional pregnancy data and maintained the existing recommendation against use during pregnancy while continuing to regard teratogenicity as an important potential risk.\[3\] Modafinil can also reduce the effectiveness of hormonal contraception, making contraception part of the preconception discussion.\[3\]

For pitolisant, current European product information says pregnancy data are limited and that it should not be used during pregnancy unless the potential benefit outweighs the potential fetal risk. Pitolisant can also reduce the effectiveness of hormonal contraceptives; the product information advises effective contraception during treatment and for at least 21 days after stopping it.\[4\]

For solriamfetol, European product information states that it should not be used during pregnancy or in women who could become pregnant and are not using effective contraception.\[5\]

For sodium oxybate, current European product information says that the available human pregnancy data are limited and that it is not recommended during pregnancy.\[6\]

Other medicines sometimes used for narcolepsy, including methylphenidate and certain antidepressants, have different evidence profiles. For example, Germany's Embryotox service notes that methylphenidate has substantially more pregnancy-exposure data than many narcolepsy-specific medicines, although possible risks still require individual assessment.

These differences are why there is no safe universal instruction such as "stop all medication immediately."

What if you become pregnant while taking narcolepsy medication?

Contact the clinician managing your medication promptly, but do not make an abrupt treatment change without medical advice.

An unplanned pregnancy can be stressful, particularly after reading warnings in a medicine leaflet. Exposure to a medication does not automatically mean that a pregnancy has been harmed.

Germany's Embryotox service specifically cautions against making independent decisions about medication or pregnancy based only on written drug-risk information. It recommends an individualized assessment that considers the condition being treated, the medicine, timing of exposure, alternatives, and maternal health.

If medication was taken before the pregnancy was recognized, a clinician can review the exact drug, dose, and timing and discuss whether any additional pregnancy monitoring is appropriate.

Does narcolepsy get worse during pregnancy?

Narcolepsy symptoms do not follow one predictable pattern during pregnancy.

Evidence is limited because narcolepsy is uncommon and prospective pregnancy studies are scarce. European experts report that narcolepsy type 1 symptoms, particularly cataplexy, may become milder during pregnancy for many patients, but they emphasize that this observation is based mainly on clinical experience and limited retrospective evidence.\[1\]

That doesn't guarantee improvement, though. Medication changes, altered nighttime sleep, pregnancy-related fatigue, nausea, physical discomfort, and changing daily routines can all affect how manageable daytime sleepiness feels. Someone who becomes substantially sleepier after a medication change can discuss that change with their sleep specialist rather than assuming severe deterioration is simply part of pregnancy.

Does narcolepsy increase pregnancy risks?

Some studies have found higher rates of certain maternal health conditions in pregnancies involving narcolepsy, but the evidence does not show that every person with narcolepsy will experience complications.

A European retrospective study examining more than 300 pregnancies in women whose narcolepsy symptoms were present during pregnancy found generally normal average gestational age and newborn birth weight. It also reported higher BMI, greater pregnancy weight gain, and more impaired glucose metabolism among some women with narcolepsy and cataplexy.\[7\]

A later US database study found associations between narcolepsy and conditions including obesity, pre-existing hypertension, diabetes, and, in part of the dataset, gestational hypertension. Because this was an observational administrative-data study, it cannot prove that narcolepsy itself caused those outcomes.\[8\]

The practical implication isn't that pregnancy with narcolepsy is automatically high risk. It's that the pregnancy-care team should know about the narcolepsy and the person's broader medical history so appropriate routine or additional monitoring can be considered.

Can cataplexy happen during labour?

Cataplexy during labour has been reported, but available evidence suggests it is uncommon.

Labour involves physical effort, pain, stress, excitement, and other strong emotions, so people with frequent cataplexy may understandably worry about an episode during delivery. In the large European retrospective study, cataplexy during delivery was reported in only three patients. Caesarean delivery was more common among women with narcolepsy and cataplexy, although cataplexy during labour itself was rare.\[7\]

Narcolepsy does not therefore automatically determine how someone should give birth. Someone with active cataplexy can discuss their typical triggers and severity with both their sleep specialist and maternity team before delivery so the team understands the condition.

How should safety be planned if sleepiness increases?

Any treatment change that increases daytime sleepiness should prompt a practical discussion about safety at home, at work, and while travelling.

This can be particularly important during the period between stopping or changing medication and establishing a workable pregnancy routine. Driving deserves special attention — if a person becomes unable to reliably stay awake, a previous assumption about fitness to drive may no longer apply. Similar considerations can arise with cooking, bathing, climbing stairs, work involving machinery, or other activities where suddenly falling asleep or experiencing cataplexy could cause injury.

Planned naps and regular sleep schedules may provide supportive structure. European narcolepsy guidance recommends planned daytime naps as a non-drug strategy, but naps are not a substitute for an individualized safety assessment or appropriate medical care.\[1\]

What should you plan for after the baby is born?

Postpartum planning should consider nighttime waking, severe sleepiness, cataplexy, medication restart, and whether another adult can help with infant care.

This is easy to overlook during pregnancy. Newborn care involves repeated nighttime waking, prolonged sleep disruption, feeding, carrying a baby, and sometimes being awake at unpredictable times. These demands can be difficult for anyone and may be particularly challenging when narcolepsy already affects sleep-wake regulation. The European pregnancy study found that narcolepsy symptoms made newborn care more difficult for many participants.\[7\]

European narcolepsy guidance also highlights nighttime infant safety when sodium oxybate is being restarted. It recommends considering whether a partner or family member can reliably oversee the infant at night because the medication produces deep sleep.\[1\]

Planning practical support before delivery can therefore be as important as planning medication.

Can you breastfeed while taking narcolepsy medication?

Breastfeeding decisions depend on the specific medication because transfer into breast milk and recommendations differ considerably.

Current European product information states that pitolisant is contraindicated during breastfeeding.\[4\] For sodium oxybate, the product information states that the medicine and/or its metabolites enter breast milk and that it should not be used while breastfeeding.\[6\] For solriamfetol, the European information confirms that it enters breast milk and advises deciding with a doctor whether to avoid breastfeeding or avoid the medicine, based on the benefits of each.\[5\]

Evidence for other medicines differs. This means a breastfeeding plan should ideally be discussed before birth, particularly if medication needs to restart quickly because daytime sleepiness or cataplexy becomes difficult to manage.

What questions are worth taking to a preconception or pregnancy appointment?

The most useful discussion connects medication risks with the practical consequences of narcolepsy in everyday life.

Questions worth covering include whether the current medication should change before conception, how long contraception needs to continue after a medication change, what the plan will be if sleepiness or cataplexy worsens, whether driving or work needs reconsideration, whether the obstetric team needs additional information about cataplexy, and what treatment and breastfeeding will look like immediately after delivery. It can also help to discuss who will provide practical support during the first weeks after birth if severe sleepiness makes nighttime infant care difficult.

For people in Germany who need detailed information about a particular medicine, Embryotox at Charité – Universitätsmedizin Berlin provides evidence-based information and individual counselling about medication exposure during pregnancy.

The central message is simple: pregnancy planning with narcolepsy is not only about reducing medication exposure. It is about finding the safest workable balance for both parent and baby.

Disclaimer: This content is informational and not a medical device. mama health offers information and support and does not replace a doctor.